Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(44.4%)

Phase 3

2(22.2%)

Phase 2

2(22.2%)

Phase 1

1(11.1%)

9Total

N/A(4)

Phase 3(2)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT00515372Phase 1Active Not Recruiting

Depression Treatment and Screening in Ovarian Cancer Patients

Role: collaborator

NCT00186992Phase 2Active Not Recruiting

Radiation Therapy to Treat Musculoskeletal Tumors

Role: collaborator

NCT00533338Not ApplicableUnknown

Weight Gain Prevention for Breast Cancer Survivors

Role: collaborator

NCT00806715Completed

Iron Overload in Stem Cell Transplant Recipients

Role: collaborator

NCT01929720Not ApplicableCompleted

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Role: collaborator

NCT00495703Phase 2Completed

The Activity Intervention for Chemobrain

Role: collaborator

NCT00660686Not ApplicableCompleted

Exercise for Physical Health in Men With Prostate Cancer

Role: collaborator

NCT00636571Not ApplicableCompleted

Feasibility of Exercise With Post-Op Lung Cancer Patients

Role: collaborator

NCT00696553Phase 3Completed

Nutrition and Resistance Training in Head and Neck Cancer

Role: collaborator

NCT00111865Phase 3Unknown

Healthy Exercise for Lymphoma Patients (HELP)

Role: lead

All 10 trials loaded